AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Bempedoic Acid 180 Mg ;

10 registrations across 1 African market— 10 active

Markets with Bempedoic Acid 180 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Barondak 180 mg
Film Coated Tablets
🇪🇬EgyptLiptis for Pharmaceuticals and Medical Productsactive
Zetacolest
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Zetacolest
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Bendovaxeed
Film Coated Tablets
🇪🇬EgyptXeedia Pharmaceuticalsactive
Markibemp
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Markibemp
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Bempetina
Film Coated Tablets
🇪🇬EgyptAVERROES PHARMA for pharmaceutical industriesactive
Barondak 180 mg
Film Coated Tablets
🇪🇬EgyptLiptis for Pharmaceuticals and Medical Productsactive
Bendovaxeed
Film Coated Tablets
🇪🇬EgyptXeedia Pharmaceuticalsactive
Bempetina
Film Coated Tablets
🇪🇬EgyptAVERROES PHARMA for pharmaceutical industriesactive

Bempedoic Acid 180 Mg ; in Africa — Regulatory Overview

Bempedoic Acid 180 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.